Tribune Therapeutics
Stockholm · est. 2020 · website↗
Registered as Tribune Therapeutics AB
Tribune Therapeutics is a preclinical biopharmaceutical company developing medicines targeting CCN protein signaling pathways for fibrotic diseases.
SurvivalNot on file yet
SectorHealth & life science
Age6 yearsest. 2020
LanguageEnglish site
Open rolesNot on file yet
Filed financials
Filed with a public registryFiled with Bolagsverket. The legal entity, not the group.
| Fiscal year | Revenue | Result | Employees | Cash | Equity | Total assets | Flags |
|---|---|---|---|---|---|---|---|
| FY2023 | under 0.1 MSEK | -38 MSEK | 1 | 32 MSEK | 65 MSEK | 68 MSEK | None |
| FY2022 | under 0.1 MSEK | -39 MSEK | 0 | 24 MSEK | 26 MSEK | 33 MSEK | None |
| FY2021 | under 0.1 MSEK | -11 MSEK | 0 | 12 MSEK | 14 MSEK | 16 MSEK | None |
Open roles
Tribune Therapeutics hires through LinkedIn, which isn't read here.
Tribune Therapeutics on LinkedIn Jobs↗Registered business activity (SNI)
Filed with a public registryStandard industry classification codes as filed with Bolagsverket.
Bioteknisk forskning och utveckling
Companies like this one
- Also Health & life science · Similar size (under 10) · Same age (6 to 10 years)
- Also Health & life science · Similar size (under 10) · Same age (6 to 10 years)
- Also Health & life science · Similar size (under 10) · Same age (6 to 10 years)
- Also Health & life science · Similar size (under 10) · Same age (6 to 10 years)
- Also Health & life science · Similar size (under 10) · Same age (6 to 10 years)
- Also Health & life science · Similar size (under 10) · Same age (6 to 10 years)
Work here?
Nobody has answered yet. Same questions for every company.
Answer for this companyOn the map
Engelbrektsplan 1, 114 34 Stockholm
Address from the company's own site.
Drawn by OpenStreetMap, so it only loads when you ask for it.